Journal of Multiple Sclerosis and Neuroimmunology

Current issue

Page Path

HOME
BROWSE ARTICLES
Current issue

Volume 17(1); Jun 2026

Review Article

이중 항체 음성 시신경척수염 범주 질환: 현재원; J Mult Scler Neuroimmunol. 2026;17(1):1-6. Published online June 30, 2026; DOI: https://doi.org/10.59578/jmsni.2026.17.1.1-6; Full text PubReader ePub PDF

Case Report

항종양괴사인자 치료 중인 크론병 환자에서 대뇌피질뇌염으로 발현한 MOG항체 연관 질환: 이주연, 석진명, 김지현; J Mult Scler Neuroimmunol. 2026;17(1):7-10. Published online June 30, 2026; DOI: https://doi.org/10.59578/jmsni.2026.17.1.7-10; Full text PubReader ePub PDF Supplementary Material

Letter to the Editor

신경면역질환 한글 의학용어 표준화를 위한 예비 조사: 말이집희소돌기아교세포당단백질항체연관질환 용어 선호도: 이혜림, 권순욱, 석진명, 김수영, 오성일, 대한신경면역학회 정책위원회; J Mult Scler Neuroimmunol. 2026;17(1):11-13. Published online June 30, 2026; DOI: https://doi.org/10.59578/jmsni.2026.17.1.11-13; Full text PubReader ePub PDF

Volume 17, No. 1

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

6,048	Autoimmune Nodopathy: When to Suspect and How to Treat?
5,193	National Consensus Guidance for Management of Refractory Myasthenia Gravis
3,875	The Clinical Utility of the Ocrelizumab for the Patients with Multiple Sclerorsis
2,927	Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder
2,833	Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis

Cited By 3	National Consensus Guidance for Management of Refractory Myasthenia Gravis
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis
Cited By 1	Collaboration between Medical Association and Patient Organizations to Overcome Rare Neurological Disorders
Cited By 1	Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2026 by Korean Society of Neuroimmunology.